HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Correspondence: Submit a response Alert me when this article is cited Alert me when Correspondence are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Erenberg, G. Articles by Rothner, A. D. Search for Related Content PubMed PubMed Citation Articles by Erenberg, G. Articles by Rothner, A. D.

Gilles de la Tourette's syndrome

Effects of stimulant drugs

From the Departments of Neurology and Pediatric and Adolescent Medicine, Cleveland Clinic Foundation, Cleveland, OH.

We reviewed the medication histories in 200 children with Gilles de la Tourette's syndrome to investigate how frequently CNS stimulants may unmask a latent syndrome or worsen existing tics. Forty-eight patients had received stimulant drugs. Nine were treated before the onset of tics, but only four were still receiving stimulants when tics began. In 39 patients with preexisting tics, stimulants increased tics in 11, caused no change in 26, and decreased tics in 2. Behavior improved in 22 patients. Thirteen of these 22 had no increase in tics when stimulants were used. Cautious trials of stimulant therapy may benefit some patients with this syndrome.

Address correspondence and reprint requests to Dr. Erenberg, Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44106.

Accepted for publication December 14, 1984.

This article has been cited by other articles:

				A. J. Allen, R. M. Kurlan, D. L. Gilbert, B. J. Coffey, S. L. Linder, D. W. Lewis, P. K. Winner, D. W. Dunn, L. S. Dure, F. R. Sallee, et al. Atomoxetine treatment in children and adolescents with ADHD and comorbid tic disorders Neurology, December 27, 2005; 65(12): 1941 - 1949. [Abstract] [Full Text] [PDF]

				H. S. Singer, S. Szymanski, J. Giuliano, F. Yokoi, A. S. Dogan, J. R. Brasic, Y. Zhou, A. A. Grace, and D. F. Wong Elevated Intrasynaptic Dopamine Release in Tourette's Syndrome Measured by PET Am J Psychiatry, August 1, 2002; 159(8): 1329 - 1336. [Abstract] [Full Text] [PDF]

				Treatment of ADHD in children with tics: A randomized controlled trial Neurology, February 26, 2002; 58(4): 527 - 536. [Abstract] [Full Text] [PDF]

				T. Spencer, J. Biederman, B. Coffey, D. Geller, T. Wilens, and S. Faraone The 4-Year Course of Tic Disorders in Boys With Attention-Deficit/Hyperactivity Disorder Arch Gen Psychiatry, September 1, 1999; 56(9): 842 - 847. [Abstract] [Full Text] [PDF]

				F. X. Castellanos Stimulants and Tic Disorders: From Dogma to Data Arch Gen Psychiatry, April 1, 1999; 56(4): 337 - 338. [Full Text] [PDF]

				D. G. Lichter and L. A. Jackson Predictors of Clonidine Response in Tourette Syndrome: Implications and Inferences J Child Neurol, March 1, 1996; 11(2): 93 - 97. [Abstract] [PDF]

				T. L. Earles and B. S. Myles Using Behavioral Interventions to Decrease Coprolalia in a Student with Tourette's Syndrome and Autism: A Case Study Focus on Autism and Other Developmental Disabilities, February 1, 1994; 8(6): 1 - 10. [Abstract] [PDF]

				K. K.S. Voeller Clinical Management of Attention Deficit Hyperactivity Disorder J Child Neurol, January 1, 1991; 6(1_suppl): S51 - S67. [Abstract] [PDF]

				R. J. Lerer Motor Tics, Tourette Syndrome, and Learning Disabilities J Learn Disabil, May 1, 1987; 20(5): 266 - 267. [Abstract] [PDF]